Old Web
English
Sign In
Acemap
>
authorDetail
>
Naomi Rahimi-Levene
Naomi Rahimi-Levene
Medicine
Immunology
Chronic lymphocytic leukemia
Blood vessel
Dorsum
4
Papers
36
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low‐dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD‐FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience
2019
Hematological Oncology
Yair Herishanu
Tamar Tadmor
Andrei Braester
Osnat Bairey
Ariel Aviv
Naomi Rahimi-Levene
Riva Fineman
Itai Levi
Mona Yuklea
Rosa Ruchlemer
Lev Shvidel
Aaron Polliack
Show All
Source
Cite
Save
Citations (5)
A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group
2018
Blood
Tamar Tadmor
Andrei Braester
Najib Dally
Ariel Aviv
Yair Herishanu
Mona Yuklea
Lev Shvidel
Naomi Rahimi-Levene
Rosa Ruchlemer
Ariela Arad
Claudia Fogl
Aaron Polliack
Lee Magal
Kelly Townsend
Show All
Source
Cite
Save
Citations (0)
Analysis of Red Cell Mass and Plasma Volume in Patients With Polycythemia
2009
Archives of Pathology & Laboratory Medicine
Mordechai Lorberboym
Naomi Rahimi-Levene
Helena Lipszyc
Chun-K. Kim
Show All
Source
Cite
Save
Citations (20)
Retropubic radical prostatectomy: associated blood loss and transfusion requirements--a two-decade perspective review.
2005
Israel Medical Association Journal
Kobi Stav
Naomi Rahimi-Levene
Arie Lindner
Yoram I. Siegel
Amnon Zisman
Show All
Source
Cite
Save
Citations (11)
1